← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2019-1:1051 | 1051 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Ropivacaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1051 | 1051 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methionine; Inositol; Choline Chloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:1051 | 1051 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylene Blue | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:1051 | 1051 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:1051 | 1051 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Meloxicam | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:1051 | 1051 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Melphalan | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:1051 | 1051 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ondansetron | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:1051 | 1051 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-8096 | 72196-8096-1 | Norepinephrine Bitartrate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1051 | 1051 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2299 | 72934-2299-4 | Niacinamide; Tretinoin | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1051 | 1051 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5022 | 26436-5022-1 | Nandrolone Decanoate | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1051 | 1051 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5183 | 26436-5183-5 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:1051 | 1051 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1051 | 1051 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:1051 | 1051 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-046 | 70092-046-46 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1051 | 1051 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:1052 | 1052 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2324 | 72934-2324-2 | Diasaxiatar Cream | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1052 | 1052 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Ropivacaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1052 | 1052 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methionine; Inositol; Succinylcholine Chloride; Cyanocobalamin | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:1052 | 1052 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71283-0619 | 71283-0619-1 | Methylprednisolone | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:1052 | 1052 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:1052 | 1052 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Melphalan | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:1052 | 1052 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Melphalan | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:1052 | 1052 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-012 | 71506-012-55 | Ondansetron Hydrochloride | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1052 | 1052 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-8097 | 72196-8097-1 | Norepinephrine Bitartrate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1052 | 1052 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1304 | 72934-1304-2 | Niacinamide; Tretinoin | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1052 | 1052 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:1052 | 1052 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5232 | 26436-5232-5 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:1052 | 1052 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1052 | 1052 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:1052 | 1052 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9010 | 71266-9010-9 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1052 | 1052 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-021 | 73198-021-05 | Phenylephrine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1053 | 1053 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-382 | 73693-382-01 | TESTOSTERONE, TRIAMCINOLONE 87.5MG, 17.5MCG | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1053 | 1053 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Ropivacaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1053 | 1053 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methionine; Inositol; Succinylcholine Chloride; Cyanocobalamin | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:1053 | 1053 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-2115 | 72907-2115-5 | Methylprednisolone Acetate | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:1053 | 1053 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-4035 | 71286-4035-5 | Midazolam Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:1053 | 1053 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Melphalan | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:1053 | 1053 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Melphalan | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:1053 | 1053 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ondansetron Hydrochloride; Ketamine Hydrochloride; Midazolam | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:1053 | 1053 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-931 | 68985-931-98 | Norepinephrine Bitartrate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1053 | 1053 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2300 | 72934-2300-2 | Niacinamide; Tretinoin | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1053 | 1053 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:1053 | 1053 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5112 | 26436-5112-5 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:1053 | 1053 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Atropine Sulfate; Papaverine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1053 | 1053 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:1053 | 1053 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9010 | 71266-9010-1 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1053 | 1053 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-045 | 70092-045-05 | Phenylephrine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1054 | 1054 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-5501 | 72934-5501-2 | Elyzia | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1054 | 1054 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Ropivacaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1054 | 1054 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-440 | 70004-440-12 | Methohexital Sodium | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:1054 | 1054 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-2115 | 72907-2115-3 | Methylprednisolone Acetate | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:1054 | 1054 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:1054 | 1054 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Melphalan | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:1054 | 1054 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Melphalan | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:1054 | 1054 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2426 | 72627-2426-1 | Ornithine; Arginine Hydrochloride; Citrulline | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1054 | 1054 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6056 | 72196-6056-1 | Norepinephrine Bitartrate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1054 | 1054 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2304 | 72934-2304-2 | Niacinamide; Tretinoin | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1054 | 1054 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 65302-501 | 65302-501-05 | Neostigmine Methylsulfate | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1054 | 1054 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5497 | 26436-5497-5 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:1054 | 1054 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Atropine Sulfate; Papaverine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1054 | 1054 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:1054 | 1054 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9010 | 71266-9010-2 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1054 | 1054 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:1055 | 1055 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6646 | 71300-6646-9 | Naltrexone HCl | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1055 | 1055 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Ropivacaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1055 | 1055 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methohexital Sodium | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:1055 | 1055 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71283-0626 | 71283-0626-2 | Methylprednisolone Acetate | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:1055 | 1055 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-130 | 71449-130-32 | Midazolam Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:1055 | 1055 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Melphalan | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:1055 | 1055 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Melphalan | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:1055 | 1055 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-0903 | 60652-0903-1 | Oxytocin | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1055 | 1055 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-027 | 71506-027-58 | Norepinephrine Bitartrate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1055 | 1055 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2306 | 72934-2306-2 | Niacinamide; Tretinoin | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1055 | 1055 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 65302-501 | 65302-501-03 | Neostigmine Methylsulfate | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1055 | 1055 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5145 | 26436-5145-5 | Papaverine Hydrochloride; Phentolamine Mesylate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:1055 | 1055 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Papaverine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1055 | 1055 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:1055 | 1055 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5230 | 71266-5230-1 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1055 | 1055 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9022 | 71266-9022-1 | Phenylephrine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1056 | 1056 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 69389-064 | 69389-064-22 | Sarracenia Purpurea | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1056 | 1056 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Ropivacaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1056 | 1056 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1505 | 5446-1505-01 | Methotrexate | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:1056 | 1056 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71283-0636 | 71283-0636-1 | Methylprednisolone Acetate | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:1056 | 1056 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-4035 | 71286-4035-1 | Midazolam Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:1056 | 1056 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Melphalan | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:1056 | 1056 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Melphalan | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:1056 | 1056 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6031 | 72196-6031-1 | Oxytocin | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1056 | 1056 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6057 | 72196-6057-1 | Norepinephrine Bitartrate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1056 | 1056 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2309 | 72934-2309-2 | Niacinamide; Tretinoin | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1056 | 1056 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1372 | 61141-1372-5 | Neostigmine Methylsulfate | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1056 | 1056 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1056 | 1056 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Papaverine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1056 | 1056 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:1056 | 1056 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-123 | 73702-123-10 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1056 | 1056 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9032 | 71266-9032-1 | Phenylephrine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1057 | 1057 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9017 | 83826-9017-8 | Prednisolone Phosphate, Moxifloxacin HCl, Ketorolac Tromethamine | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1057 | 1057 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Ropivacaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1057 | 1057 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5015 | 26436-5015-3 | Methylcobalamin | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:1057 | 1057 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71283-0625 | 71283-0625-2 | Methylprednisolone Acetate | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:1057 | 1057 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-4033 | 71286-4033-2 | Midazolam Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:1057 | 1057 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Melphalan | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:1057 | 1057 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1241 | 5446-1241-01 | Methacholine Chloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:1057 | 1057 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6036 | 72196-6036-1 | Oxytocin | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1057 | 1057 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:1057 | 1057 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2307 | 72934-2307-2 | Niacinamide; Tretinoin | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1057 | 1057 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6065 | 72196-6065-1 | Neostigmine Methylsulfate | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1057 | 1057 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1057 | 1057 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1057 | 1057 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:1057 | 1057 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-108 | 73177-108-03 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1057 | 1057 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-108 | 73177-108-03 | Phenylephrine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1058 | 1058 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5356 | 26436-5356-1 | TESTOSTERONE 3mg | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1058 | 1058 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Ropivacaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1058 | 1058 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylcobalamin | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:1058 | 1058 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 62295-3119 | 62295-3119-1 | Methylprednisolone Acetate | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:1058 | 1058 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-4035 | 71286-4035-3 | Midazolam Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:1058 | 1058 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72833-881 | 72833-881-01 | Metformin Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:1058 | 1058 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-538 | 69374-538-03 | Methacholine Chloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:1058 | 1058 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6037 | 72196-6037-1 | Oxytocin | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1058 | 1058 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-127 | 73198-127-30 | Ondansetron | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1058 | 1058 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-510 | 71170-510-25 | Norepinephrine | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1058 | 1058 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-139 | 63037-139-25 | Neostigmine Methylsulfate | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1058 | 1058 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1058 | 1058 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1058 | 1058 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:1058 | 1058 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:1058 | 1058 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6008 | 72196-6008-1 | Phenylephrine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1059 | 1059 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 80098-030 | 80098-030-90 | ISOSULFAN BLUE | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1059 | 1059 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Finasteride | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1059 | 1059 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylcobalamin | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:1059 | 1059 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-916 | 69852-916-10 | Methylprednisolone Acetate | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:1059 | 1059 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-4035 | 71286-4035-2 | Midazolam Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:1059 | 1059 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1248 | 5446-1248-01 | Methacholine Chloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:1059 | 1059 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-536 | 69374-536-50 | Methacholine Chloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:1059 | 1059 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6038 | 72196-6038-1 | Oxytocin | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1059 | 1059 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ondansetron Hydrochloride; Ketamine Hydrochloride; Midazolam | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:1059 | 1059 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-117 | 73702-117-03 | Norepinephrine | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1059 | 1059 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-125 | 71449-125-11 | Neostigmine Methylsulfate | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1059 | 1059 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1059 | 1059 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1059 | 1059 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:1059 | 1059 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-001 | 71449-001-11 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1059 | 1059 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6058 | 71285-6058-1 | Phenylephrine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1060 | 1060 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0431 | 71285-0431-1 | Trophamine 3.5%/Dextrose 10% and Heparin 125 units 250ml bag | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1060 | 1060 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Finasteride; Minoxidil | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1060 | 1060 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylcobalamin | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:1060 | 1060 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-115 | 69852-115-10 | Methylprednisolone Acetate | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:1060 | 1060 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:1060 | 1060 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1246 | 5446-1246-01 | Methacholine Chloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:1060 | 1060 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-539 | 69374-539-03 | Methacholine Chloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:1060 | 1060 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6039 | 72196-6039-1 | Oxytocin | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1060 | 1060 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2426 | 72627-2426-1 | Ornithine Hydrochloride; Arginine Hydrochloride; Citrulline | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1060 | 1060 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-118 | 73702-118-03 | Norepinephrine | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1060 | 1060 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:1060 | 1060 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1060 | 1060 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1060 | 1060 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:1060 | 1060 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-001 | 71449-001-15 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1060 | 1060 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7011 | 71285-7011-1 | Phenylephrine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1061 | 1061 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2321 | 72934-2321-2 | Diaoxia Cream | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1061 | 1061 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Finasteride; Minoxidil | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1061 | 1061 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylcobalamin | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:1061 | 1061 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-1065 | 71266-1065-1 | Methylprednisolone Acetate | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:1061 | 1061 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-411 | 70004-411-56 | Midazolam Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:1061 | 1061 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1241 | 5446-1241-01 | Methacholine Chloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:1061 | 1061 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-537 | 69374-537-03 | Methacholine Chloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:1061 | 1061 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6042 | 72196-6042-1 | Oxytocin | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1061 | 1061 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-0012 | 71139-0012-1 | Oxytocin | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1061 | 1061 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-116 | 73702-116-03 | Norepinephrine | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1061 | 1061 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2003 | 71266-2003-2 | Neostigmine Methylsulfate | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1061 | 1061 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1061 | 1061 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1061 | 1061 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9031 | 71266-9031-1 | Phenylephrine Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:1061 | 1061 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6058 | 71285-6058-1 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1061 | 1061 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-7084 | 71139-7084-2 | Phenylephrine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1062 | 1062 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5558 | 26436-5558-5 | NAD | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1062 | 1062 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Finasteride; Minoxidil | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1062 | 1062 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylcobalamin | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:1062 | 1062 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71283-0623 | 71283-0623-1 | Methylprednisolone Acetate; Bupivacaine Hydrochloride | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:1062 | 1062 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-411 | 70004-411-59 | Midazolam Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:1062 | 1062 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1249 | 5446-1249-01 | Methacholine Chloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:1062 | 1062 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-540 | 69374-540-03 | Methacholine Chloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:1062 | 1062 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6045 | 71285-6045-1 | Oxytocin | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1062 | 1062 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6037 | 72196-6037-1 | Oxytocin | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1062 | 1062 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-115 | 73702-115-03 | Norepinephrine | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1062 | 1062 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2003 | 71266-2003-1 | Neostigmine Methylsulfate | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1062 | 1062 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1062 | 1062 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1062 | 1062 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:1062 | 1062 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7025 | 71285-7025-1 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1062 | 1062 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-178 | 71449-178-15 | Phenylephrine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1063 | 1063 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1595 | 72934-1595-2 | Kynara Gel | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1063 | 1063 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Finasteride; Minoxidil | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1063 | 1063 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylcobalamin | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:1063 | 1063 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-8025 | 73271-8025-1 | Methylprednisolone Acetate; Lidocaine | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:1063 | 1063 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-4036 | 71286-4036-1 | Midazolam Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:1063 | 1063 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1247 | 5446-1247-01 | Methacholine Chloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:1063 | 1063 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1248 | 5446-1248-01 | Methacholine Chloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:1063 | 1063 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-028 | 71506-028-59 | Oxytocin | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1063 | 1063 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6038 | 72196-6038-1 | Oxytocin | 2022-2 | valid | 0 | 2026-10-17 |